India’s First Medicine to Treat Duchenne Muscular Dystrophy Cleared for Clinical Trials
After 13 years of research, India’s first personalized medicine for Duchenne muscular dystrophy (DMD) has received the green signal from the Drug Controller General of India (DCGI), paving the way for clinical trials.